NeurAegis
Michel Baudry is currently the Chief Scientific Advisor at NeurAegis. Michel has also previously served as the Chief Scientific Officer at Rhenovia Pharma and as a Professor at USC. Dr. Baudry began their career as a postdoc at UC Irvine.
Dr. Baudry is a highly accomplished scientist with a wealth of experience in the pharmaceutical and academic industries. Michel has made significant contributions to their field and has played a key role in the development of several important drugs.
Dr. Baudry is a respected authority on neuroscience and has authored numerous papers on the topic. Michel is also an active member of several professional organizations.
Michel Baudry completed a PhD at the Univ Paris and then attended the École Polytechnique.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
NeurAegis
NeurAegis is a preclinical stage neuropharmaceutical company pioneering the development of breakthrough treatments for neurological disorders.